All In Biotech

Drug Trial Radar · NCT02055781

Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia

A Randomized Controlled Phase 3 Study of Oral Pacritinib Versus Best Available Therapy in Patients With Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

Last checked: Nov 20, 2026Latest source record: Nov 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 311 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

311

Actual

Start

Feb 2014

Primary completion

Apr 2016

Study completion Apr 2016

Sponsor

Lead sponsor
CTI BioPharmaIndustry
Sponsor type
Industry
First posted
Feb 5, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 3, randomized, controlled study to evaluate the safety and efficacy of oral pacritinib compared to Best Available Therapy (BAT) in patients with thrombocytopenia and primary or secondary myelofibrosis.

Conditions

  • Primary Myelofibrosis
  • Post-polycythemia Vera Myelofibrosis
  • Post-essential Thrombocythemia Myelofibrosis

Interventions

  • PacritinibDrug

  • Best Available TherapyDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Spleen Volume ReductionTime frame: Baseline to Week 24
  2. Total Symptom Score (TSS) ReductionTime frame: Baseline to Week 24

Locations

122 sites in 12 countries. Site status is shown where the registry gives one.

  • Mayo Clinic Arizona

    Scottsdale, Arizona

  • Arizona Clinical Research Center

    Tucson, Arizona

  • City of Hope

    Duarte, California

  • Moores Cancer Centre

    La Jolla, California

  • USC Norris Comprehensive Cancer Center

    Los Angeles, California

  • Stanford Cancer Center

    Stanford, California

  • Rocky Mountain Cancer Center

    Boulder, Colorado

  • George Washington University- Medical Faculty Associates

    Washington D.C., District of Columbia

  • SCRI- Florida Cancer Specialists South Region

    Fort Myers, Florida

  • SCRI - Florida Cancer Specialists North Region

    St. Petersburg, Florida

  • H. Lee Moffitt Cancer Center & Research Institute

    Tampa, Florida

  • Northwestern University

    Chicago, Illinois

  • Carle Cancer Center

    Urbana, Illinois

  • Indiana University Goshen Cancer Centre

    Goshen, Indiana

  • Investigative Clinical Research of Indiana

    Indianapolis, Indiana

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Siouxland Hematology-Oncology Associates, L.L.P (SHOA)

    Sioux City, Iowa

  • Norton Cancer Institute, Suburban

    Louisville, Kentucky

  • St Joseph Mercy Hospital

    Ann Arbor, Michigan

  • University of Michigan

    Ann Arbor, Michigan

  • Henry Ford Health System

    Detroit, Michigan

  • Providence Cancer Institute

    Southfield, Michigan

  • Washington University School of Medicine Division of Oncology

    St Louis, Missouri

  • Nebraska Hematology-Oncology, P.C.

    Lincoln, Nebraska

  • Hackensack University

    Hackensack, New Jersey

  • Hematology-Oncology Associates of Northern Jersey

    Morristown, New Jersey

  • New Mexico Cancer Care Alliance

    Albuquerque, New Mexico

  • Mount Sinai Medical Center

    New York, New York

  • Columbia University Medical Center

    New York, New York

  • Stony Brook University Medical Center

    Stony Brook, New York

  • SCRI-Oncology Hematology Care

    Cincinnati, Ohio

  • Cleveland Clinic-Taussig Cancer Center

    Cleveland, Ohio

  • University of Oklahoma

    Oklahoma City, Oklahoma

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • UPMC Hillman Cancer Center

    Pittsburgh, Pennsylvania

  • Upstate Oncology Associates

    Greenville, South Carolina

  • Sarah Cannon Research Institute (SCRI)

    Nashville, Tennessee

  • Texas Onocolgy-Baylor Sammons Cancer Center

    Dallas, Texas

  • UT Southwestern Medical Center

    Dallas, Texas

  • UTMB Galveston

    Galveston, Texas

Showing 40 of 122 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.